Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/14/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Daniel Khesin?

Daniel Khesin

Chief Executive Officer

divineskin.com

Email: d***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Chief Executive Officer

DS Laboratories Inc


Investments

The DK Design Group


Web References(112 Total References)


Capixyl & Astressin-B: New Hair Regrowth Ingredients Gaining Attention | Stem Cell Baldness Cures

stemcellbaldnesscures.com [cached]

"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin.
"So we are especially excited that the resulting product will be reasonably priced as well as cutting-edge, considering the extraordinary development schedule and cost." Astressin-B sparked extensive media coverage worldwide and excitement around the biotech industry after a clinical study, conducted by the University of California Los Angeles and the Veterans Administration, was published in February. By applying the peptide (a protein fragment) subcutaneously to mice that had gone bald due to overexpression of stress hormones, scientists showed that astressin-B blocked receptors for corticotropin-releasing factor, involved in the stress response, and led to hair regrowth. "We think this technology is years ahead of its time," continued Khesin.


Introducing the First Astressin-B Topical Solution for Hair Loss! | Stem Cell Baldness Cures

stemcellbaldnesscures.com [cached]

"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin.
"We think this technology is years ahead of its time," continued Khesin.


Capixyl & Astressin-B: New Hair Regrowth Ingredients Gaining Attention | Stem Cell Baldness Cures

stemcellbaldnesscures.com [cached]

"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin.
"So we are especially excited that the resulting product will be reasonably priced as well as cutting-edge, considering the extraordinary development schedule and cost." Astressin-B sparked extensive media coverage worldwide and excitement around the biotech industry after a clinical study, conducted by the University of California Los Angeles and the Veterans Administration, was published in February. By applying the peptide (a protein fragment) subcutaneously to mice that had gone bald due to overexpression of stress hormones, scientists showed that astressin-B blocked receptors for corticotropin-releasing factor, involved in the stress response, and led to hair regrowth. "We think this technology is years ahead of its time," continued Khesin.


Introducing the First Astressin-B Topical Solution for Hair Loss! | Stem Cell Baldness Cures

stemcellbaldnesscures.com [cached]

"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin.
"We think this technology is years ahead of its time," continued Khesin.


Technology | Undiscovered Equities

undiscoveredequities.com [cached]

Divine Skin CEO Daniel Khesin stated, "I believe this move will not only boost our current revenue but also be a significant asset to Divine Skin's human resources.
"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory